Olga Calof is an Endocrinology/Metabolic physician affiliated with Drew University. OpenAlex indexes 12 publications with 1,164 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1499 W 1st St
San Pedro, CA 907323255
Telephone
310-831-9482Provider last certified this registry record 29 Mar 2021.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Dexcom, Inc.Program year20258 payments
- Abbott LaboratoriesProgram year202510 payments
- Novo Nordisk IncProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
63.3%Insulin Analog16.7%Humalog Kwikpen U-10022%Lantus Solostar21%Tresiba Flextouch U-10016%Basaglar Kwikpen U-1007%Novolog Flexpen7%Toujeo Solostar6%Toujeo Max Solostar5%Fiasp Flextouch4%Tresiba Flextouch U-2004%Insulin Lispro Kwikpen U-1003%Novolog3%Lyumjev Kwikpen U-1002%Part D<11 patientsGLP-1 receptor agonist14.9%Ozempic50%Mounjaro20%Trulicity16%Rybelsus14%Part D≥54 patients+ 8 more classes in this area
Hormonal (systemic)
18.2%l-Thyroxine15.3%Levothyroxine Sodium82%Synthroid18%Part D≥109 patientsThyroid Hormone Synthesis Inhibitor1.7%Methimazole100%Part D≥15 patients+ 2 more classes in this area
Cardiovascular
16.5%Statin7.5%Atorvastatin Calcium70%Rosuvastatin Calcium13%Simvastatin10%Pravastatin Sodium7%Part D<11 patientsACE inhibitor3.1%Lisinopril100%Part D≥28 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2007–2009 per NIH RePORTER. The latest:
- CLINICAL TRIAL: PELVIC FLOOR EVALUATION IN POST-MENOPAUSAL WOMEN
Charles R. Drew University of Med & Sci
FY2009$1,597P20RR011145 - TESTOSTERONE REPLACEMENT IN POSTMENOPAUSAL WOMEN W/ STRESS URINARY INCONTINENCE
Charles R. Drew University of Med & Sci
FY2009$1,597P20RR011145 - CLINICAL TRIAL: PELVIC FLOOR EVALUATION IN POST-MENOPAUSAL WOMEN
Charles R. Drew University of Med & Sci
FY2008$19,164P20RR011145
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Drug Insight: testosterone and selective androgen receptor modulators as anabolic therapies for chronic illness and aging
Nature Clinical Practice Endocrinology & Metabolism
2006 - Adverse Events Associated With Testosterone Replacement in Middle-Aged and Older Men: A Meta-Analysis of Randomized, Placebo-Controlled Trials
The Journals of Gerontology Series A
2005 - Effects of Testosterone Replacement in Human Immunodeficiency Virus-Infected Women with Weight Loss
The Journal of Clinical Endocrinology & Metabolism
2005
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”